Amneal Pharmaceuticals Inc Class A (AMRX)

Total Costs & Expenses

$650.22M

Quarterly · Period ending: · USD

AMRX logo

AMRX Total Costs & Expenses

Latest reported$650.22M
AMRX Quarterly Total Costs & Expenses ($222.72M → $650.22M)
High-resolution chart · PNG

AMRX total costs & expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Amneal Pharmaceuticals Inc Class A Total Costs & Expenses — Quarterly (USD)
Period endingTotal Costs & Expenses (USD)
650,217,000
579,649,000
699,817,000
784,630,000
613,136,000
595,073,000
654,725,000
613,659,000
606,310,000
669,937,000
602,788,000
544,392,000
518,962,000
523,091,000
573,727,000
501,204,000
757,973,000
474,328,000
525,721,000
500,078,000
467,956,000
447,198,000
489,856,000
516,859,000
453,911,000
440,742,000
420,463,000
428,357,000
417,201,000
505,500,000
435,890,000
401,857,000
342,877,000
204,500,000
215,145,000
195,176,000
215,186,000
168,256,000
222,720,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.